SUMMARY Severe abnormalities of plasma electrolyte concentrations were observed in 4 children who had massive hyperlipidaemia secondary to poorly-controlled, insulin-dependent diabetes mellitus. These electrolyte values were fallacious and invoked problems of clinical management, particularly with regard to fluid repla^ement. Each case is described and the interpretation of plasma electrolyte values in hyperlipidaemia is discussed.
Moderately raised serum lipids and lipoproteins often are found in adults with diabetes mellitusI-3 and in diabetic children4-both before and after treatment. Severe hyperlipidaemia in association with diabetes is however much less common. 7 We describe 4 children with insulin-dependent diabetes who developed massive hyperlipidaemia associated with a variable degree of metabolic decompensation. In all 4 patients the plasma electrolyte values were fallaciously low.
Case reports Case 1. An 11-year-old girl was admitted acutely ill, with a 3-month history of progressive weight loss, increased appetite, polydipsia, and polyuria. On examination she was pale, thin, clinically dehydrated, and had florid lipaemia retinalis. Her urine contained sugar, ketones, and protein. Blood glucose was moderately raised at 17-1 mmol/l (308 mg/100 ml) and plasma electrolytes were abnormal with plasma sodium of 98 mmol/l (Table 1) , arterial blood hydrogen ion concentration [H+] 74 nmol/l (pH 7 13), and bicarbonate <6 0 mmol/l. Her blood was lipaemic on inspection and severe hyperlipidaemia was confirmed biochemically (Table 1) .
Shortly after admission she became drowsy with Kussmaul's respirations, and then she vomited. Intravenous fluids were started: 0 45 % saline with potassium supplements, alternating with 5 % dextrose. Soluble insulin was administered by continuous intravenous infusion at a rate of 3 units hourly, which was increased to 10 units hourly over 8 hours. Blood glucose remained unchanged during the first 12 hours of treatment, but the plasma electrolytes improved with the serum osmolality falling to 289 mmol/kg, and the carbon dioxide (CO2) content rising to 15-0 mmol/l. The next day intravenous soluble insulin was replaced by monocomponent insulin, 6 units hourly by intramuscular injection, and 10 g carbohydrate drinks were given every 2 hours. After 48 hours blood glucose had returned to normal with normal arterial [H+] but the plasma CO2 content was still apparently low (13-5 mmol/l). On day 5 a diet was started, which contained 170 g carbohydrate and 30 g fat (1700 calories). (Fig. 3) A method for calculating the true electrolyte concentrations, based on the serum triglyceride concentration has been described.'2 Alternatively, the lipids can be extracted from a plasma aliquot with carbon tetrachloride before measuring the electrolyte concentration in the aqueous phase (Table 2) . Plasma osmolality is a useful guide to treatment, as it is unaffected by the presence of excess lipid9 and may demonstrate a discrepancy between plasma osmolality and electrolyte concentrations.
The severity of the acidosis does not correlate with the degree of hyperlipidaemia and may be relatively mild with only a moderate increase in blood glucose (Cases 1 and 2). Arterial hydrogen ion concentration (pH) could be used in such cases to assess the degree of metabolic acidosis, since the estimated plasma bicarbonate or CO2 concentration is also misleading.
Potassium replacement has to be empirical because of the difficulty of monitoring plasma potassium levels. In children, concurrent renal disease is unlikely and the risk of producing hyperkalaemia is small if the urinary output is satisfactory.
In such cases the insulin requirement may be much greater than 2 to 6 units hourly although this is generally adequate to treat diabetic ketoacidosis. The delayed biochemical improvement in Case 1 was caused by an inadequate amount of insulin being given for several hours after treatment was initiated. A fat-free diet eliminated any contribution of exogenous fat to the hyperlipidaemia; the reintroduction of fat to the diet of 2 patients (Cases 1 and 2) produced a return of fasting chylomicronaemia, and probably delayed the resolution of the hyperlipidaemia in Case 3.
The hyperlipidaemia was classified as type V15 in the patients in whom lipoprotein electrophoresis was studied. None of these 4 patients had a family history of lipid disorder, and the fasting serum lipids were normal in all of the first-degree relatives of Cases 1, 2, and 4 (the relatives of Case 3 were not examined). This suggests that the hyperlipidaemia was secondary to the metabolic disturbance associated with the diabetes. Hyperlipidaemia of this magnitude seems to develop over a period of several weeks, or perhaps longer. Lipoprotein lipase activity is subnormal in association with insulin deficiency,7 and results in a decreased removal of circulatory lipid from the serum,16 but the mechanism by which this massive hyperlipidaemia is produced is not clear.
The degree of hyperlipidaemia was particularly severe in the child who died (Case 4). Severe hyperlipidaemia may predispose to increased platelet aggregation and blood hyperviscosity with thrombus formation,7 1-8 and these factors were probably responsible for the extensive intracerebral thrombosis found at necropsy. Theoretically, it might be supposed that heparin could be used to stimulate lipoprotein lipase activity, and help to prevent the consequences of the associated hypercoagulation state. However, by the time this degree of hyperlipidaemia has developed, the lipoprotein lipase enzyme system has probably been exhausted, and it is doubtful if administration of heparin would be of benefit.
Although 
